Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Generic enzyme 7b
[{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f941/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f941/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f940/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f940/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93f/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93f/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93e/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93e/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93d/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93d/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93c/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93c/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93b/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93b/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f93a/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f93a/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f939/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f939/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f938/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f938/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f937/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f937/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f936/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f936/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f935/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f935/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f934/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f934/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f933/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f933/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f932/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f932/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f931/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f931/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f930/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f930/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92f/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92f/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92e/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92e/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92d/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92d/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92c/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92c/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92b/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92b/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f92a/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f92a/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f929/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f929/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f928/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f928/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f927/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f927/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f926/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f926/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f925/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f925/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f924/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f924/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f923/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f923/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f922/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f922/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f921/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f921/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f920/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f920/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91f/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91f/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91e/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91e/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91d/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91d/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91c/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91c/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91b/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91b/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f91a/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f91a/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f919/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f919/5d2ce15ff02f730400c4f917.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5d2ce1b6f02f730400c4f918/5d2ce15ff02f730400c4f917.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5d2ce1b6f02f730400c4f918/5d2ce15ff02f730400c4f917.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
SIGN UP FREEKeywords
receptor,ligand,target ligand,targeting ligand,targeted ligand,protein,pathway,signaling,cascade,diagram,transcription factor,generic,catalyst,enzyme,substrate,lock and key
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
